Peptide receptor radionuclide therapy for neuroendocrine tumours: standardized and randomized, or personalized?

被引:0
|
作者
Michael S. Hofman
Rodney J. Hicks
机构
[1] Centre for Cancer Imaging,Molecular Imaging
[2] Peter MacCallum Cancer Centre,Department of Medicine
[3] The University of Melbourne,Centre for Cancer Imaging
[4] Peter MacCallum Cancer Centre,undefined
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:211 / 213
页数:2
相关论文
共 50 条
  • [21] Targeted Alpha Particle Therapy for Neuroendocrine Tumours: The Next Generation of Peptide Receptor Radionuclide Therapy
    Navalkissoor, Shaunak
    Grossman, Ashley
    NEUROENDOCRINOLOGY, 2019, 108 (03) : 256 - 264
  • [22] Lutetium-177 Dotatate peptide receptor radionuclide therapy outcomes for neuroendocrine tumours
    AlHilali, M.
    Carberry, J.
    Challis, A.
    Atherton, P.
    RADIOTHERAPY AND ONCOLOGY, 2023, 182 : S1095 - S1096
  • [23] Peptide Receptor Radionuclide Therapy In Broncopulmonary Neuroendocrine Tumours - Results Of A Single Centre Experience
    Ferreira, G.
    Castro, S.
    Costa, C.
    Violante, L.
    Teixeira, J.
    Duarte, H.
    Sampaio, I. L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S89 - S89
  • [24] Molecular profiling of neuroendocrine tumours to predict response and toxicity to peptide receptor radionuclide therapy
    Bodei, Lisa
    Schoeder, Heiko
    Baum, Richard P.
    Herrmann, Ken
    Strosberg, Jonathan
    Caplin, Martyn
    Oeberg, Kjell
    Modlin, Irvin M.
    LANCET ONCOLOGY, 2020, 21 (09): : E431 - E443
  • [25] Peptide receptor radionuclide therapy of neuroendocrine tumors
    Haug, A. R.
    Bartenstein, P.
    ONKOLOGE, 2011, 17 (07): : 602 - +
  • [26] Peptide Receptor Radionuclide Therapy of Neuroendocrine Tumors
    Bodei, Lisa
    Kidd, Mark
    Prasad, Vikas
    Modlin, Irvin M.
    NEUROENDOCRINE TUMORS: A MULTIDISCIPLINARY APPROACH, 2015, 44 : 198 - 215
  • [27] Peptide Receptor Radionuclide Therapy of Neuroendocrine Tumors
    Basu, Sandip
    Parghane, Rahul, V
    Kamaldeep
    Chakrabarty, Sudipta
    SEMINARS IN NUCLEAR MEDICINE, 2020, 50 (05) : 447 - 464
  • [28] Peptide receptor radionuclide therapy as a potential tool for neoadjuvant therapy in patients with inoperable neuroendocrine tumours (NETs)
    Sowa-Staszczak, Anna
    Pach, Dorota
    Chrzan, Robert
    Trofimiuk, Malgorzata
    Stefanska, Agnieszka
    Tomaszuk, Monika
    Kolodziej, Maciej
    Mikolajczak, Renata
    Pawlak, Dariusz
    Hubalewska-Dydejczyk, Alicja
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 (09) : 1669 - 1674
  • [29] Peptide receptor radionuclide therapy as a potential tool for neoadjuvant therapy in patients with inoperable neuroendocrine tumours (NETs)
    Anna Sowa-Staszczak
    Dorota Pach
    Robert Chrzan
    Małgorzata Trofimiuk
    Agnieszka Stefańska
    Monika Tomaszuk
    Maciej Kołodziej
    Renata Mikołajczak
    Dariusz Pawlak
    Alicja Hubalewska-Dydejczyk
    European Journal of Nuclear Medicine and Molecular Imaging, 2011, 38
  • [30] A dosimetric comparison of systemic peptide receptor radionuclide therapy and intra-arterial peptide receptor radionuclide therapy in patients with liver dominant gastroenteropancreatic neuroendocrine tumours
    Nautiyal, Amit
    Jha, Ashish K.
    Konuparamban, Acsah
    Mithun, Sneha
    Srichandan, Tusharkanta
    Puranik, Ameya
    Gala, Kunal
    Shetty, Nithin
    Kulkarni, Suyash
    Rangarajan, Venkatesh
    NUCLEAR MEDICINE COMMUNICATIONS, 2023, 44 (07) : 585 - 595